Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.
Also called NCT02150824
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 103 participants
- Sponsor
- Registry
-
NCT02150824 -
2013-003646-16
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT02150824. Randomized; double masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2015-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- BI 187004
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- BI 187004
- Intervention (Drug)
- BI 187004
- Intervention (Drug)
- BI 187004
- Lead sponsor
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct02150824- Content hash
0f551e1e4168cd62a4c4e58c99b0522c1f9d8611cb17c60b556ad8ae81aeebc6